1. The document discusses gut microbiota and its relationship to health. It provides background on methods used to study the microbiome, such as next generation sequencing and fecal transplantation.
2. Intrinsic and extrinsic factors that influence microbiome composition are examined, including genetics, diet, medication, and disease states. Many diseases are associated with distinct microbiome profiles.
3. Studies of population cohorts explore the effects of various factors on the microbiome and identify biomarkers. Comparisons of healthy, IBS, and IBD groups show differences in taxonomic profiles and metabolic pathways between conditions.
On the horizon: Critical Care and the Microbiome - Hallie PrescottIntensive Care Society
This is Hallie Prescott's presentation from the opening plenary session at the Intensive Care Society State of the Art Meeting 2018
Dr. Hallie Prescott is an Assistant Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She leads grants on post sepsis morbidity and hospital performance measurement from the US National Institutes of Health and the US Department of Veteran’s Affairs. She is an expert in long-term outcomes and recovery after sepsis, with a focus on preventable hospital readmissions. She is co-chair of the Surviving Sepsis Campaign guidelines, inaugural Lowry-Fink fellow of the International Sepsis Forum (2017-2019), a former ANZICS Intensive Care Global Rising Star fellow (2015), and winner of the Early Career Achievement award from the American Thoracic Society’s Critical Care Assembly (2018).
On the horizon: Critical Care and the Microbiome - Hallie PrescottIntensive Care Society
This is Hallie Prescott's presentation from the opening plenary session at the Intensive Care Society State of the Art Meeting 2018
Dr. Hallie Prescott is an Assistant Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She leads grants on post sepsis morbidity and hospital performance measurement from the US National Institutes of Health and the US Department of Veteran’s Affairs. She is an expert in long-term outcomes and recovery after sepsis, with a focus on preventable hospital readmissions. She is co-chair of the Surviving Sepsis Campaign guidelines, inaugural Lowry-Fink fellow of the International Sepsis Forum (2017-2019), a former ANZICS Intensive Care Global Rising Star fellow (2015), and winner of the Early Career Achievement award from the American Thoracic Society’s Critical Care Assembly (2018).
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gianfranco Tammaro
PROF. ANTONIO GASBARRINI - 3° Giornata Master ECM in Gastroenterologia 2016 (25/11/2016) - Fondazione Santa Lucia - Sala Congressi - Roma
Sito: www.asmad.net
Canale Youtube: https://youtu.be/ouYcXg_ZtJM
Moving into the Post-MetagenomicEra of Gut Microbiome ResearchJonathan Clarke
Julian Marchesi's presentation slides from our previous Microbiome R&D and Business Collaboration Forum. For information about this years event please visit http://www.globalengage.co.uk/microbiota.html
A review report on detailed study of research endeavours, undertaken on Human Microbiome, its composition, its implications, applications, disease and other role.
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...IFSMED
Rheumatologist Dr. Alex Shikhman makes the connection between ankylosing spondylitis and the gut. Offering natural dietary supplements to help manage many of the side effects associated with the disease
Patologie digestive, extradigestive e MicrobiotaASMaD
Presentazione a cura del Professor Giovanni Barbara - M.A.S.T.E.R. ECM in Gastroenterologia: Focus on: Microbiota e dintorni - Fondazione Santa Lucia - Roma
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gianfranco Tammaro
PROF. ANTONIO GASBARRINI - 3° Giornata Master ECM in Gastroenterologia 2016 (25/11/2016) - Fondazione Santa Lucia - Sala Congressi - Roma
Sito: www.asmad.net
Canale Youtube: https://youtu.be/ouYcXg_ZtJM
Moving into the Post-MetagenomicEra of Gut Microbiome ResearchJonathan Clarke
Julian Marchesi's presentation slides from our previous Microbiome R&D and Business Collaboration Forum. For information about this years event please visit http://www.globalengage.co.uk/microbiota.html
A review report on detailed study of research endeavours, undertaken on Human Microbiome, its composition, its implications, applications, disease and other role.
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...IFSMED
Rheumatologist Dr. Alex Shikhman makes the connection between ankylosing spondylitis and the gut. Offering natural dietary supplements to help manage many of the side effects associated with the disease
Patologie digestive, extradigestive e MicrobiotaASMaD
Presentazione a cura del Professor Giovanni Barbara - M.A.S.T.E.R. ECM in Gastroenterologia: Focus on: Microbiota e dintorni - Fondazione Santa Lucia - Roma
Effect of Antibiotics on The Gut Microbiota in Children with Chronic Pancreat...JohnJulie1
Little is known about the effect of antibiotic treatment on the gut microbiota in children with chronic pancreatitis (CCP). Our objective was to identify the effect of antibiotic treatment on the gut microbiota in children with chronic pancreatitis (CCP), the main gut microbiota genera and characterize the patients’ functional mutations after using antibiotics.
Presentazione a cura del Professor Cesare Cremon - M.A.S.T.E.R. ECM in Gastroenterologia: Focus on: Microbiota e dintorni - Fondazione Santa Lucia - Roma
Impact of gut microbes on gastrointestinal diseaseSandra Unorji
Gut microbes have been identified play a role in both health and disease. Surprisingly, we are outnumbered by them which raises questions that has led to several research with interesting results.
Probiotics goes beyond digestive and immune health. At the recent Microbiome R&D and Business Collaboration Congress: Asia, DuPont Nutrition & Health shared on how probiotics can influence vaginal microbiota and provide positive health benefits such as weight management for the user.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
7. Fecal transplantation in clinical practice
Rates of Cure without Relapse for
Recurrent Clostridium difficile Infection.
van Nood E et al. N Engl J Med 2013;368:407-415.
11. Several parameters are commonly studied in microbiome analysis
• Diversity of bacteria in every individual
• Composition of microbiome in general
• Abundance of particular bacteria
• Abundance of functional categories (group of
bacterial genes)
12. Richness and diversity
Sample 1
Less different bacteria
Sample 2
More different bacteria
Richness: the number of species in the sample
Richness sample 1 < richness sample 2
Diversity: richness and evenness (how many species and
how evenly are they distributed)
13. Overall composition of microbiome in the population (Bray-Curtis distance matrix)
Compositional dissimilarity between samples
Example of microbiome composition in Belgian population (Falony et al, Science, 2016)
14. Example of PCA plot of IBD patients vs controls, based on 16S data
Imhann et al, Gut, 2015
16. Abundance of functional groups
Bacteria 1 Bacteria 2 Bacteria 3
6 “green” genes in this population of bacteria
Types of “green” genes can be different, for example:
Antibiotic resistance,
Bacterial pathways,
Virulence factors,
Etc
20. Microbiome composition is highly variable across individuals
Figure from io9.gizmondo.com
We do not know all factors that influence these variations
21. Microbiome composition is highly variable across individualsgenera
> 1000 samples
LifeLines Deep, Netherlands
23. Lifelines DEEP: ~1500 random participants with detailed multi-‘omics’ data
Age: 18-86
636 903
Tigchelaar et al., BMJ Open 2015
RNAseq on PBMCs
Illumina 450k arrays
Exhaled air (VOCs)
Plasma (lipidomics)
16S rRNA
Metagenomics WGS
Olink, Cytokines
8 mi imputed SNP genotypes
24. Analysis of multiple factors in relation to microbiome composition
44
39
41
5
68
Included 207 intrinsic and external factor analysis in
populational cohort of 1135 individuals
Zhernakova, Science, 2016
26. Belgium cohort: similar results, 92% replication
Falony et al. (2016) Science 352;6285: 560-56416S rRNA based data
27. Proton Pump Inhibitors massively change the microbiota composition
44 categories
of drugs
28. PPI: Significant changes in abundance of 92 bacteria; replicated in 3 cohorts
General
population
IBD
patients
IBS case
control
Meta-
analysis
Direction
Red: up
Blue: down
Imhann, et al, Gut, 2015
32. Strong correlation of antibiotics with several species
NO
1122
YES
13
Bifidobacteriumlongum
p=1.97e−05
q=0.0036
Bifidobacterium longum and Roseburia inulinivorans are
decreased in antibiotic-users
Roseburia_inulinivorans
NO
1122
YES
13
p=0.00171
q=0.103
35. Biomarkers for gut health
Citrulline
Calprotectin
IL-1β and IL-6
IL-12p70 and TNF
function
HBD-2
Chromogranin A
Adapted from Bischoff, BMC Medicine, 2011
38. Stool frequency and stool composition have major effect on microbiome
BM
p.Firmicutes
k. Archaea
Average number bowel movements per day
Bacterialabundance
Firmicutes
BM Archaea
Tigchelaar et al, Gut, 2015
39. Jankipersadsing et al., Gut 2016
LifeLines-Deep (N=1546) and PopCol Sweden (N=284):
1. Evidence for roles for xenobiotic metabolism (CYP8B1; AHR;
ALDH1A1, etc)
2. Ion channel activity pathways (ion channels as anti-IBS drugs!)
Stool frequency is determined by genetics
0.00
10.00
20.00
30.00
40.00
50.00
60.00
<1 per day 1 per day 1-2 per day >2 per day
Percentage
Stool frequency in LifeLines-Deep study
All
Female
Male
With Mauro D’Amato
40. Jankipersadsing et al., Gut 2016
LifeLines-Deep (N=1546) and PopCol Sweden (N=284):
1. Evidence for roles for xenobiotic metabolism (CYP8B1; AHR;
ALDH1A1, etc)
2. Ion channel activity pathways (ion channels as anti-IBS drugs!)
Stool frequency is determined by genetics
44. Diet is a major modulator of
gut microbiome variation
Some enrich diversity (green)
Others decrease diversity (red)
carbohydrates
fruit
beer
kcal
coffee
soda/sugar
butter milk
whole-fat milk
tea
yogurt
vegetables
red wine
45.
46. Examples of food effect on specific bacteria
Increased
abundance of
Eubacterium
eligens
Beneficial role in maintaining the
normal gut ecology, butyrate production
51. Interaction of LCT genotype with milk intake and microbiome
Discovery:
Lifelines-DEEP
N=984
Replication:
Two cohorts
N=529
Meta-analysis:
N=1,514
40 hits (5x10-8)
52. Example of effect of LCT polymorphism on microbiome composition
People with genetic lactase deficiency
have increased abundance of
bifidobacteria
People with genetic lactase deficiency
consume same amount of dairy
products
Bonder, Kurilshikov et al, Nat.Genetics, 2016
53. Interaction analysis in LCT locus
Interaction of consumption of diary products and genetic lacatase
deficiency lead to high abundance of bifidobacteria.
Bifidobacteria can have lactase function and help digesting milk
54. Genetics of gut microbiome: 4 GWAS studies in cohorts of >1000 individuals
N=1,812
N=1,561
N=1,514
N=2,139
55. Genetics of gut microbiome: 4 GWAS studies in cohorts of >1000 individuals
N=1,812
N=1,561
N=1,514
N=2,139
56. Current studies in genetics of gut microbiome
Kurilshikov, Trends Imm, 2017
Wang et al, submitted
LCT gene is associated with
bifidobacteria abundance in
Dutch and TwinUK GWAS
Innate immune receptors are
enriched in results
57. MiBioGen consortium: meta-analysis of miQTL studies
If you have samples with genetics and microbiome please contact me: Sasha.zhernakova@gmail.com
Cohort name Ethnicity variable region N subjects
SHIP / SHIP-TREND German V1-V2 1904
PopGen German V1-V2 912
FoCus German V1-V2 1555
Compuls Dutch V1-V2 153
CARDIA USA V3-V4 282
Rotterdam Study Dutch V3-V4 1427
Generation R Multi-ethnic V3-V4 2111
Pers.Nutrition Israel V3-V4 1066
KSCS South Korea V3-V4 833
TwinsUK UK V4 1793
COPSAC2010 Danish V4 424
GEM Canada, Israel, US, UK V4 1543
LifeLines-DEEP Dutch V4 1089
METSIM Finnish V4 531
MIBS_Co Dutch V4 111
NTR Dutch V4 499
FGFP Flemish V4 2482
Total samples 18715
59. 3. Gut health is a continuum: link with microbiome
Healthy
No gut complaints
FGID IBS IBD
Research aims:
Identify biomarkers for diagnostic of IBS,
IBD and other gut diseases
Novel treatment and prevention of IBS and IBD
controls
N=1025
Pop-IBS
N=218
Clin-IBS
N=182
IBD
N=355
>200 clinical phenotypes: diet, medication, clinical characteristics, serology, etc
62. Taxonomical analysis: Large dysbiosis
Crohn vs Controls:
134 species
UC vs Controls:
58 species
IBS vs Controls:
37 species
63. Taxonomical analysis: Dynamics and within-species richness
In IBD/IBS patients:
increased diversity of some pathogenic bacteria (E. coli)
Decreased diversity of beneficial bacteria (F. prausnitzii)
Vich Vila, et al, submitted
64. Pathway implication
L-arginine
- Decreased in CD, ileal surgery
- Involved in wound healing
Tryptophan (serotonin
precursor)
- Increased in IBS, especially
IBS-D
- Serotonin can increase gut
motility and visceral pain
Vitamin B2
- Decreased in CD / antioxidant
Kennedy et al, WJG, 2014
Dozens of pathways and virulence factors are associated to IBD
and/or IBS – link to function
65. Genetic risk score for IBD genes change the microbiota composition in controls
• Two risk scores composed
1 - All 200 IBD-associated variants
2 - Hypothesis-based: 11 functional variants
• 5 genes (NOD2, CARD9, FUT2, ATG16L1, IRGM)
- Related to IBD
- Function
- Literature: related to microbiome changes
66. Genetic IBD risk in healthy individuals associated with decreased Roseburia
- Healthy individuals
- Without gut complaints
- Higher IBD genetic risk
- Differences microbiome
Roseburia is decreased in IBD
patients
IBD genetic risk – pre-IBD
microbiome changes.
FDR=0.017
Co-factors: age, sex, BMI, antibiotics, PPI, read depth
Imhann et al, Gut, 2016
67. 10-fold cross validation:
90% training set
10% testing set
Calprotectin levels (AUC=0.79)
Microbiome (AUC= 0.91)
Top-20 taxa + Calprotectin
(AUC=0.93)
Microbiome-based prediction model to distinguish between IBD/IBS
68. Diet and gut microbiome
Healthy
No gut complaints
FGID IBS IBD
Clustering of food items and microbial
features
Analysis per cohort -> meta-analysis
Significant association of 25 clusters of food
with 29 clusters of species (FDR<0.05)
controls
N=1025
Pop-IBS
N=218
Clin-IBS
N=182
IBD
N=355
Laura Bolte
69. Inverse Effects of Plant vs. Animal Protein
-
+
SCFA producers
Bifidobacteria
Lactic bacteria
F. prausnitzii
Eubacteria
Bacteroides
Carbohydrate
fermentation
Pyruvate, fructose to
propanoate,
butanoate, acetate,
lactate
Starch degradation
Plant protein
Animal protein
70. Polyphenols and Omega-3 rich foods boost SCFA-producers
+
SCFA producers,
mucin producers
Eubacterium spp
Bifidobacterium spp
F. prausnitzii
R. hominis
A. muciniphila
Carbohydrate
fermentation
Pyruvate, fructose to
propanoate,
butanoate, acetate,
lactate, …
Starch degradation
Foods rich in
polyphenols or
n-3 FA
- Potentially
harmful species
H. parainfluenzae
E. Coli
B. Fragilis
71. Probiotics effective in 10k metagenome project DAG-3
Ongoing: effect of probiotics on gut microbiome in 10 K metagenome project DAG-3.
Analysis of small pilot data set.
Probiotic drinks
-
Dorea spp.
• Gas producing bacteria
• Increased in IBS patients
73. GFD is one of the most common diet
No wheat, barley and rye
10% australians are of GFD (5% males, 15% females)
Only treatment for celiac disease
Helpful by gluten intolerance
Helpful by IBS
Catassi et al, Nutrients, 2013
74. Study design
Time →
Habitual diet
Gluten free diet (4 weeks)
Wash out period (5 weeks)
T=0 T=1 T=2 T=3 T=4 T=5 T=6 T=7 T=8
Stool sample
Exhaled breath sample
Blood sample
Permeability test
5 random days food record
21 individuals, 9 time points
76. (Weak) split for 2 groups based on richness
One sample in between groups
No difference in GFD effect in high and low richness group
77. Strongest associations on taxonomic level – Veillonellacea family
• Strongest association:
Decrease in Veillonellacea on
GFD
• Pro-inflammatory bacteria
• Maybe linked with
“improvement” of gut
symptoms on GFD
• Replication: also decreased in
autistic patients (many on
GFD)
• Overall moderate effect of GFD
on gut microbiome
Veillonellaceae
81. Other opportunities and research questions of LifeLines-NEXT
Oral microbiome and saliva in
mothers and babies
(pregnancy complications,
allergies, strain stability across
body sites…)
The role of vaginal microbiome
Long term effect of microbiome
on health
Genetics of microbiome
…..
82. Oral bacteria might protect against allergies
Hesselmar et al (2013) (Slide from E.Zaura)
Parental sucking of their infant’s pacifier was associated
with a reduced risk of allergy development
83. Organs on a chip: how gut bacteria communicate with the host
85. Take home messages
• Gut microbiome varies greatly among individuals
• Gut microbiome is influenced by food, medication,
lifestyle, genetics, etc
• Gut microbiome is associated to many diseases, the
causal role is proven for several diseases
• Power of cohorts studies to identify gene-
microbiome-environmental interactions and
relations to health
88. Acknowledgements
UMCG Groningen
Cisca Wijmenga
Jingyuan Fu
Marc Jan Bonder
Arnau Vich Villa
Ettje Tigchelaar
Soesma Medema-
jankipersadsing
Alexandr Kurilshikov
Rinse Weersma
Floris Imhann
Eelke Brandsma
Marten Hofker
Jackie Dekens
University medical center
Maastricht
Daisy Jonkers
Zlatan Mujagic
Radboud University
Mihai Netea
Sanne Smeekens
Marije Oosting
Leo Joosten
Broad Institute/MHG
Boston
Melanie Schirmer
Ramnik Xavier
Tommi Vatanen
Curtis Huttenhower
MiBioGen consortium
89. Acknowledgements
UMCG Groningen
Cisca Wijmenga
Jingyuan Fu
Marc Jan Bonder
Arnau Vich
Ettje Tigchelaar
Soesma Medema-
jankipersadsing
Alexandr Kurilshikov
Rinse Weersma
Floris Imhann
Eelke Brandsma
Marten Hofker
Jackie Dekens
University medical center
Maastricht
Daisy Jonkers
Zlatan Mujagic
Frederik-Jan van
Schooten
Agnieszka Smolinska
Broad Institute/MHG
Boston
Melanie Schirmer
Ramnik Xavier
Wageningen University
Erwin Zoetendal
Hauke Smidt
Looking for PhD students and postdocs
in the microbiome group!
Sasha.zhernakova@gmail.com
Editor's Notes
Nutrient and fluid > uptake marker
Serotonin increased in IBS
Correlate SCFA with microbiome
Correltae all with VOCs (general gut health)